# Curavit Clinical Research Corp — Form D

Curavit Clinical Research Corp of SCARSDALE, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-13. The offering totals $8.9M, of which $8.5M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2022-10-13
- Form: D
- Accession: 0001947723-22-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $8.9M
- Amount sold: $8.5M
- Remaining: $400K
- Investors: 26
- Date of first sale: 2022-09-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-461679

## Issuer

- Name: Curavit Clinical Research Corp
- CIK: 0001947723
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 18 LARCH LANE, SCARSDALE, NY, 10583
- Phone: 917-885-0024

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Nathanael Lentz | Director | Spokane, WA |
| Jackie Kent | Director | Scarsdale, NY |
| Rich Lester | Director | Scarsdale, NY |
| Joel Morse | Director | Scarsdale, NY |
| Joel Morse | Executive Officer | Scarsdale, NY |
| David Hanaman | Director | Scarsdale, NY |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-09-05](https://search.stillhousedata.com/formd/0001947723-24-000002) | D/A | $11.6M | $11.4M |
| [2024-03-08](https://search.stillhousedata.com/formd/0001947723-24-000001) | D/A | $10.4M | $10.1M |

## More

- [CIK 1947723 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1947723&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001947723-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.
